MARCUZZI, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 6.202
AS - Asia 3.327
EU - Europa 1.701
SA - Sud America 702
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 87
OC - Oceania 2
Totale 12.223
Nazione #
US - Stati Uniti d'America 6.027
SG - Singapore 1.291
CN - Cina 720
BR - Brasile 549
PL - Polonia 476
IT - Italia 439
VN - Vietnam 421
HK - Hong Kong 317
BD - Bangladesh 157
FR - Francia 155
DE - Germania 127
GB - Regno Unito 112
RU - Federazione Russa 96
ID - Indonesia 82
CA - Canada 75
JP - Giappone 67
IN - India 64
AR - Argentina 59
UA - Ucraina 55
FI - Finlandia 50
SE - Svezia 50
TR - Turchia 49
MX - Messico 46
NL - Olanda 38
ZA - Sudafrica 38
AT - Austria 23
IQ - Iraq 20
CO - Colombia 19
ES - Italia 19
MY - Malesia 18
PK - Pakistan 17
EC - Ecuador 16
VE - Venezuela 16
CL - Cile 15
UZ - Uzbekistan 15
JM - Giamaica 13
AE - Emirati Arabi Uniti 12
IE - Irlanda 11
PH - Filippine 10
PY - Paraguay 10
CR - Costa Rica 9
SA - Arabia Saudita 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
HN - Honduras 8
KE - Kenya 8
MA - Marocco 8
NP - Nepal 8
BE - Belgio 7
LT - Lituania 7
TH - Thailandia 7
TN - Tunisia 6
AZ - Azerbaigian 5
EG - Egitto 5
SN - Senegal 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RO - Romania 4
TW - Taiwan 4
CI - Costa d'Avorio 3
ET - Etiopia 3
KR - Corea 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
SV - El Salvador 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
GP - Guadalupe 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
MD - Moldavia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
EU - Europa 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
Totale 12.013
Città #
Ashburn 859
Fairfield 685
Singapore 682
San Jose 474
Warsaw 472
Woodbridge 356
Santa Clara 342
Hong Kong 311
Beijing 277
Seattle 274
Council Bluffs 267
Houston 266
Cambridge 240
Wilmington 207
Dallas 152
Ho Chi Minh City 140
Hanoi 100
Los Angeles 94
New York 86
Ann Arbor 85
Ferrara 82
Lauterbourg 76
Princeton 73
Tokyo 62
Chicago 61
Jakarta 60
Chandler 59
São Paulo 55
Milan 48
San Diego 48
Moscow 45
Shanghai 40
Munich 39
Jacksonville 38
London 38
Orem 29
Buffalo 27
Nuremberg 26
Helsinki 25
Montreal 25
Mexico City 24
Rio de Janeiro 24
Atlanta 22
Brooklyn 21
Dong Ket 20
Johannesburg 20
Bologna 19
Denver 19
Haiphong 19
Toronto 19
Boardman 17
Chennai 17
Jinan 17
Nanjing 17
Manchester 16
Amsterdam 15
Frankfurt am Main 15
Phoenix 15
Rome 15
Stockholm 14
Tashkent 14
Da Nang 13
Poplar 13
Salt Lake City 13
Aprilia 12
Brasília 12
Hải Dương 12
Izmir 12
Boydton 11
Changsha 11
Falls Church 11
Figino 11
Miami 11
Ankara 10
Boston 10
Elk Grove Village 10
Istanbul 10
Kingston 10
Perugia 10
Shenyang 10
Belo Horizonte 9
Campinas 9
Dublin 9
Kuala Lumpur 9
Mumbai 9
Paris 9
Redwood City 9
San Francisco 9
The Dalles 9
Turku 9
Assago 8
Baghdad 8
Columbus 8
Detroit 8
Lappeenranta 8
Las Vegas 8
Milwaukee 8
Norwalk 8
San José 8
Verona 8
Totale 8.086
Nome #
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children 455
Neuronal dysfunction associated with cholesterol deregulation 274
Cytokine levels in the serum of healthy subjects 243
Type I interferon-mediated autoinflammation due to DNase II deficiency 236
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 220
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 220
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 218
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 216
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 208
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 202
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011) 196
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 195
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 193
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 190
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 187
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 185
A common genetic background could explain early-onset Crohn's disease 184
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 181
Putative modifier genes in mevalonate kinase deficiency 177
Innovative target therapies are able to block the inflammation associated with dysfunction of the cholesterol biosynthesis pathway 174
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 173
Alendronate, a double-edged sword acting in the mevalonate pathway 172
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 167
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 165
Role of vitamin D in the pathogenesis of atheromatosis 165
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 164
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al 161
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 161
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 160
Clinical Genetic Testing of Periodic Fever Syndromes 159
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 156
Database tools in genetic diseases research 155
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 154
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency 153
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration 152
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 151
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 149
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 149
The effect of clodronate on a mevalonate kinase deficiency cellular model 146
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 146
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line 144
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 143
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide 142
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes 139
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 136
Presence of IL-9 in paired samples of human colostrum and transitional milk 136
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 130
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 126
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 125
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 120
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 115
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 112
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 112
Inflammation profile of four early onset Crohn patients 111
Serum amyloid A and cholesterol: a pivotal role on inflammation 109
Post-irradiation hyperamylasemia is a prognostic marker for allogeneic hematopoietic stem cell transplantation outcomes in pediatric population: A retrospective single-centre cohort analysis 108
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 107
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders 107
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 106
MitoQ is able to modulate apoptosis and inflammation 106
New Mechanisms in Autoinflammatory Diseases 105
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency 104
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency 104
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 104
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis 103
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation 103
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes 101
Mevalonate kinase deficiency and IBD: shared genetic background 101
Evolutionary hypothesis of the Mevalonate Kinase Deficiency 93
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 92
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 92
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 91
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 90
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches 87
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 82
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 79
Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches 77
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 74
Long non-coding RNA GAS5 and intestinal MMP2 and MMP9 expression: A translational study in pediatric patients with IBD 72
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 70
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 68
Mevalonate kinase deficiency: Disclosing the role of mevalonate pathway modulation in inflammation 62
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 58
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study 56
Family history in early-onset inflammatory bowel disease 55
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 40
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 40
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 39
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 17
Analytical Profiling of Inflammation-associated Volatile Metabolites: HS-SPME to an in vitro model of Human Skin Fibroblasts 13
Trained immunity in the inflammatory cascade of chronic inflammatory skin diseases: possible checkpoints and new therapeutic targets 5
Totale 12.223
Categoria #
all - tutte 69.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022412 0 0 15 12 11 49 41 40 20 71 22 131
2022/2023310 85 9 19 14 15 24 14 17 47 4 43 19
2023/2024373 33 38 28 9 32 22 20 22 16 20 18 115
2024/20251.776 27 37 168 67 218 158 56 67 266 316 279 117
2025/20265.518 422 388 474 766 720 288 484 332 517 654 264 209
2026/2027687 173 319 195 0 0 0 0 0 0 0 0 0
Totale 12.223